These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3092269)

  • 1. The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects.
    Higgitt A; Lader M; Fonagy P
    Psychopharmacology (Berl); 1986; 89(4):395-403. PubMed ID: 3092269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788.
    Darragh A; Lambe R; O'Boyle C; Kenny M; Brick I
    Psychopharmacology (Berl); 1983; 80(2):192-5. PubMed ID: 6410450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects.
    Bonetti EP; Pieri L; Cumin R; Schaffner R; Pieri M; Gamzu ER; Müller RK; Haefely W
    Psychopharmacology (Berl); 1982; 78(1):8-18. PubMed ID: 6292984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaco-EEG and psychometric studies with a novel selective benzodiazepine agonist/antagonist Ro 23-0364.
    Saletu B; Grünberger J; Cepko H
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):421-37. PubMed ID: 2888736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The partial benzodiazepine agonist properties of Ro 15-1788 in pentylenetetrazol-induced seizures in cats.
    Kaijima M; Le Gal La Salle G; Rossier J
    Eur J Pharmacol; 1983 Sep; 93(1-2):113-5. PubMed ID: 6414826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agonism, tolerance, and rebound.
    Gentil V; Tavares S; Gorenstein C; Bello C; Mathias L; Gronich G; Singer J
    Psychopharmacology (Berl); 1990; 100(1):54-9. PubMed ID: 2104987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.
    File SE; Pellow S
    Psychopharmacology (Berl); 1986; 88(1):1-11. PubMed ID: 3003778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of visual function in healthy subjects after administration of Ro 15-1788.
    Lupolover Y; Safran AB; Desangles D; de Weisse C; Meyer JJ; Bousquet A; Assimacopoulos A
    Eur J Clin Pharmacol; 1984; 27(4):505-7. PubMed ID: 6440793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic effects of Ro 15-1788 on spontaneous petit mal-like seizures in rats.
    Marescaux C; Micheletti G; Vergnes M; Depaulis A; Rumbach L; Warter JM
    Eur J Pharmacol; 1984 Jul; 102(2):355-9. PubMed ID: 6434331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation.
    Schöpf J; Laurian S; Le PK; Gaillard JM
    Pharmacopsychiatry; 1984 May; 17(3):79-83. PubMed ID: 6429677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convulsions induced by submaximal dose of pentylenetetrazol in mice are antagonized by the benzodiazepine antagonist Ro 15-1788.
    Grecksch G; de Carvalho LP; Venault P; Chapouthier G; Rossier J
    Life Sci; 1983 May; 32(22):2579-84. PubMed ID: 6406779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of adenosine accumulation by a CNS benzodiazepine antagonist (Ro 15-1788) and a peripheral benzodiazepine receptor ligand (Ro 05-4864).
    Morgan PF; Lloyd HG; Stone TW
    Neurosci Lett; 1983 Oct; 41(1-2):183-8. PubMed ID: 6417576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of the benzodiazepine antagonist Ro 15-1788 in humans after sleep withdrawal.
    Emrich HM; Sonderegger P; Mai N
    Neurosci Lett; 1984 Jun; 47(3):369-73. PubMed ID: 6433243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects and benzodiazepine antagonist activity of Ro 15-1788 (flumazepil) in pigeons.
    Witkin JM; Barrett JE
    Life Sci; 1985 Oct; 37(17):1587-95. PubMed ID: 2932617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of the anticonvulsant effects of diazepam on amygdaloid-kindled seizures by a specific benzodiazepine antagonist: RO 15-1788.
    Le Gal La Salle G; Feldblum S
    Eur J Pharmacol; 1982 Dec; 86(1):91-3. PubMed ID: 6819154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with Ro 15-1788 distinguishes between its benzodiazepine antagonist, agonist and inverse agonist properties.
    File SE; Dingemanse J; Friedman HL; Greenblatt DJ
    Psychopharmacology (Berl); 1986; 89(1):113-7. PubMed ID: 3090585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiogenic and non-anxiogenic benzodiazepine antagonists.
    Prado de Carvalho LP; Grecksch G; Chapouthier G; Rossier J
    Nature; 1983 Jan; 301(5895):64-6. PubMed ID: 6296684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ro 15-1788 antagonizes the effects of diazepam in man without affecting its bioavailability.
    O'Boyle C; Lambe R; Darragh A; Taffe W; Brick I; Kenny M
    Br J Anaesth; 1983 Apr; 55(4):349-56. PubMed ID: 6404290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.